ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Georgia » Endocrinology, Diabetes Metabolism

Top Endocrinology, Diabetes Metabolism Prescribers in Georgia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
Y SIDDIQ M.D.

Endocrinology, Diabetes Metabolism

25,931

$2.04M

1246
805 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 46%

$79
Average prescription price

Avg: $120

JOSEPH DEHAVEN M D

Endocrinology, Diabetes Metabolism

19,788

$1.85M

852
718 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 46%

$93
Average prescription price

Avg: $120

MICHAEL VAVRIK M.D.

Endocrinology, Diabetes Metabolism

15,186

$1.77M

880
550 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 46%

$116
Average prescription price

Avg: $120

THOMAS JONES MD

Endocrinology, Diabetes Metabolism

14,619

$1.89M

1353
903 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 46%

$129
Average prescription price

Avg: $120

STEVEN LEICHTER M.D.

Endocrinology, Diabetes Metabolism

10,262

$1.17M

770
504 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 46%

$114
Average prescription price

Avg: $120

GARRY AUGUST MD

Endocrinology, Diabetes Metabolism

10,073

$1.06M

560
431 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 46%

$105
Average prescription price

Avg: $120

AHED MANSOURA MD

Endocrinology, Diabetes Metabolism

9,840

$1.28M

691
394 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 46%

$130
Average prescription price

Avg: $120

JENNIFER LAWRENCE M.D.

Endocrinology, Diabetes Metabolism

9,226

$1.27M

567
356 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 46%

$138
Average prescription price

Avg: $120

AMATU RABBI M.D.

Endocrinology, Diabetes Metabolism

8,471

$609K

400
359 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 46%

$72
Average prescription price

Avg: $120

DARWIN BROWN M.D.

Endocrinology, Diabetes Metabolism

7,735

$903K

640
475 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 46%

$117
Average prescription price

Avg: $120

TALLAPRAGADA SHANKAR MD

Endocrinology, Diabetes Metabolism

7,342

$524K

402
273 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 46%

$71
Average prescription price

Avg: $120

MATTHEY HARRIS M.D.

Endocrinology, Diabetes Metabolism

7,187

$921K

528
384 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 46%

$128
Average prescription price

Avg: $120

JOHN CHIP REED M.D.

Endocrinology, Diabetes Metabolism

6,801

$1.06M

642
524 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 46%

$156
Average prescription price

Avg: $120

SEYMOUR ROSENBLOOM MD

Endocrinology, Diabetes Metabolism

6,698

$602K

663
588 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 46%

$90
Average prescription price

Avg: $120

DAVID ROBERTSON M.D.

Endocrinology, Diabetes Metabolism

6,501

$726K

447
322 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 46%

$112
Average prescription price

Avg: $120

CHRISTINA KILE MD

Endocrinology, Diabetes Metabolism

6,434

$1.05M

557
338 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 46%

$163
Average prescription price

Avg: $120

DAVID ZIEMER MD

Endocrinology, Diabetes Metabolism

6,336

$558K

781
503 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 46%

$88
Average prescription price

Avg: $120

DAVID JACOBSON M.D.

Endocrinology, Diabetes Metabolism

6,314

$695K

675
530 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 46%

$110
Average prescription price

Avg: $120

CHRISTOPHER NEWTON MD

Endocrinology, Diabetes Metabolism

6,263

$595K

713
437 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 46%

$95
Average prescription price

Avg: $120

MARY THOMPSON M.D.

Endocrinology, Diabetes Metabolism

6,169

$623K

417
342 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 46%

$101
Average prescription price

Avg: $120

BRUCE BODE M.D.

Endocrinology, Diabetes Metabolism

6,134

$856K

423
311 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 46%

$139
Average prescription price

Avg: $120

PATRICK BOWEN M.D>

Endocrinology, Diabetes Metabolism

5,872

$951K

583
392 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 46%

$162
Average prescription price

Avg: $120

YSSA SAADDINE MD

Endocrinology, Diabetes Metabolism

5,839

$472K

411
296 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 46%

$81
Average prescription price

Avg: $120

PETER VANDYCK MD

Endocrinology, Diabetes Metabolism

5,743

$557K

498
399 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 46%

$97
Average prescription price

Avg: $120

JAMES STOEVER D.O.

Endocrinology, Diabetes Metabolism

5,701

$912K

524
380 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

58%
prescriptions for brand name drugs

Avg: 46%

$160
Average prescription price

Avg: $120

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank